The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeted next generation sequencing in well-differentated/dedifferentiated liposarcoma (WD/DD LPS): Multiple gene amplifications but few mutations.
 
Neeta Somaiah
Research Funding - Immune Design
 
Hannah Beird
No Relationships to Disclose
 
Kenna Rael Shaw
No Relationships to Disclose
 
Wei-Lien Wang
No Relationships to Disclose
 
Anthony Paul Conley
No Relationships to Disclose
 
Vinod Ravi
No Relationships to Disclose
 
Keila E Torres
No Relationships to Disclose
 
Davis Ingram
No Relationships to Disclose
 
Christina Lynn Roland
No Relationships to Disclose
 
Vivek Subbiah
No Relationships to Disclose
 
Barry W. Feig
No Relationships to Disclose
 
Alexander J. F. Lazar
No Relationships to Disclose
 
Robert S. Benjamin
Stock and Other Ownership Interests - Express Scripts (I); Gilead Sciences (I); Johnson & Johnson (I); Merck Serono (I); Pfizer (I)
Travel, Accommodations, Expenses - PharmaMar
 
Shreyaskumar Patel
Consulting or Advisory Role - CytRx Corporation; Janssen; Novartis
Research Funding - Eisai; Janssen; Morphotek
 
Patrick Hwu
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb; Genentech
 
Andrew Futreal
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche; Sysmex
Consulting or Advisory Role - Genentech; Novartis; Roche
Research Funding - AstraZeneca; Bayer; Calithera Biosciences; Debiopharm Group; Genentech; Novartis; Taiho Pharmaceutical
 
David S. Hong
Consulting or Advisory Role - Amgen; Eisai; H3 Biomedicine; Janssen; Merck